ENTO
Entero Therapeutics
ENTO
ENTO
8 hedge funds and large institutions have $75.2K invested in Entero Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
77% less capital invested
Capital invested by funds: $332K → $75.2K (-$257K)
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$26.4K | |
| 2 | +$5.07K | |
| 3 | +$1.6K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$253 |
Top Sellers
| 1 | -$241K | |
| 2 | -$11K | |
| 3 | -$5.09K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
-$64 |
| 5 |
KSWA
Kathleen S. Wright Associates
Pittsburgh,
Pennsylvania
|
-$59 |